ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NRXP NRX Pharmaceuticals Inc

0.3199
0.0151 (4.95%)
Last Updated: 14:03:56
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -52.98M-15.71M-9.6M-9.14M-9.89M-9.44M-8.19M-5.81M
Pre Tax Income -30.79M-13.45M-6.98M-9.08M-10.24M-11.04M-8.72M-6.06M
Net Income -30.79M-13.45M-6.98M-9.08M-10.24M-11.04M-8.72M-6.06M
Preferred Dividends -255.82M0000000
Basic Earnings Per Share (EPS) 00000000
EBIT -32.04M-13.6M-7.12M-9.14M-10.39M-11.21M-8.85M-6.17M
EBITDA -52.98M-15.7M-9.6M-9.14M-9.89M-9.43M-8.19M-5.81M
Year End December 30 2022 201720182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00010.16M771k0
Operating Income -134k-1.01M-713k-51.39M-115.8M-44.34M
Pre Tax Income -105k82k492k-51M-93.06M-39.75M
Net Income -105k66k408k-51M-348.89M-39.75M
Preferred Dividends 0000-255.82M0
Basic Earnings Per Share (EPS) -0.0410.0240.143-18.972-5.932-0.598
EBIT -134k-1.01M-713k-51.05M-94.86M-40.26M
EBITDA -134k-1.01M-713k-51.39M-115.79M-44.33M

Your Recent History

Delayed Upgrade Clock